Fresenius Medical Care AG & Co. KGaA (FMS)
Automate Your Wheel Strategy on FMS
With Tiblio's Option Bot, you can configure your own wheel strategy including FMS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol FMS
- Rev/Share 66.4351
- Book/Share 52.8423
- PB 1.0158
- Debt/Equity 0.7529
- CurrentRatio 1.461
- ROIC 0.0365
- MktCap 14599907384.1134
- FreeCF/Share 6.7587
- PFCF 7.3622
- PE 23.6183
- Debt/Assets 0.3306
- DivYield 0.0244
- ROE 0.0438
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
4 Value Picks That Could Weather Tariff Volatility and Slowing Growth
Published: March 24, 2025 by: Zacks Investment Research
Sentiment: Negative
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. FMS, ENS, GM & ITRI boast a low P/CF ratio.
Read More
4 Top PEG Stocks Based on GARP Approach to Smart Investing
Published: March 20, 2025 by: Zacks Investment Research
Sentiment: Neutral
Here are four discounted PEG stocks, JAZZ, FMS, DAN and ITRI, which qualify our screening criteria.
Read More
Is Fresenius Medical Care AG & Co. (FMS) Stock Undervalued Right Now?
Published: March 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
3 Stocks Trading Near 52-Week High With Room to Rise Further
Published: March 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors target stocks that have been on a bullish run lately. Stocks like FMS, DTEGY and THG are seeing price strength and the momentum is likely to continue.
Read More
Best Momentum Stock to Buy for March 18th
Published: March 18, 2025 by: Zacks Investment Research
Sentiment: Positive
ASLE, FMS and TEF made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 18, 2025.
Read More
Why Fresenius (FMS) is a Top Momentum Stock for the Long-Term
Published: March 18, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here's Why Fresenius (FMS) is a Strong Value Stock
Published: March 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock?
Published: March 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Top 3 Medical Instruments Industry Stocks to Ride the GenAI Boom
Published: February 27, 2025 by: Zacks Investment Research
Sentiment: Positive
FMS, MASI and VCYT from the Zacks Medical Instruments industry are worth buying based on genAI adoption, strategic developments and strong fundamentals. Yet, geopolitical complications and wage and supply issues mar the prospects.
Read More
Fresenius Medical Q4 Earnings Beat Estimates, Revenues Up Y/Y
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Positive
FMS' fourth-quarter results showcase a strong segmental performance along with providing full year 2025 outlook for revenue growth and operating income.
Read More
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025
Published: February 25, 2025 by: PRNewsWire
Sentiment: Neutral
Organic revenue growth1 of 4% driven by Care Enablement and Care Delivery Underlying U.S. same market treatment growth further accelerated in Q4 and turned positive for the full year Accumulated savings of the FME25 program already reached EUR 567 million and 2025 target raised to EUR 750 million With 18% operating income2 growth top end of the 2024 outlook range reached Reported operating income grew by 2%, reported net income3 by +8% Net financial leverage ratio reduced from 3.2x to 2.9x and dividend is planned to be raised by 21% High teens to high twenties percent earnings growth in 2025, …
Read More
Fresenius Medical Care slightly beats market estimates in fourth quarter
Published: February 25, 2025 by: Reuters
Sentiment: Positive
Fresenius Medical Care , the world's largest dialysis specialist, reported fourth quarter results slightly above market expectations on Tuesday, citing positive development both in its care delivery and care enablement segments.
Read More
Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics
Published: February 24, 2025 by: PRNewsWire
Sentiment: Neutral
Quest to provide comprehensive dialysis-related laboratory and water testing services to Fresenius Medical Care owned and affiliated clinics in the United States BAD HOMBURG, Germany and SECAUCUS, N.J. , Feb. 24, 2025 /PRNewswire/ -- Fresenius Medical Care (XETRA: FME; NYSE: FMS), the world's leading provider of products and services for individuals with renal disease, and Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that, under terms of a definitive acquisition agreement, Quest will acquire select assets of FME's wholly owned Spectra Laboratories, a leading provider of renal-specific laboratory testing services in the U.S. In addition, …
Read More
About Fresenius Medical Care AG & Co. KGaA (FMS)
- IPO Date 1996-09-17
- Website https://www.freseniusmedicalcare.com
- Industry Medical - Care Facilities
- CEO Ms. Helen Giza
- Employees 112035